Amphastar Pharmaceuticals (AMPH) Enterprise Value (2013 - 2026)
Amphastar Pharmaceuticals (AMPH) posted quarterly Enterprise Value of -$171.1 million for Q1 2026, up 6.47% year-over-year from -$160.7 million in Q1 2025, and little changed quarter-over-quarter from -$170.4 million in Q4 2025.
Amphastar Pharmaceuticals (AMPH) Enterprise Value (2013 - 2026) Analysis & Trends
Amphastar Pharmaceuticals' Enterprise Value history runs 14 years deep, the most recent figure standing at -$171.1 million for Q1 2026.
- In Q1 2026, Enterprise Value rose 6.47% year-over-year to -$171.1 million; the TTM figure through Mar 2026 stood at -$171.1 million (up 6.47% YoY), while the FY2025 annual figure was -$170.4 million, down 10.79% from the prior year.
- Enterprise Value for Q1 2026 stood at -$171.1 million, roughly flat from -$170.4 million in the prior quarter.
- The five-year high for Enterprise Value was -$144.5 million in Q4 2023, with the low at -$271.0 million in Q3 2023.
- The 5-year median for Enterprise Value is -$172.8 million (2022), against an average of -$181.3 million.
- The sharpest annual moves came in 2022 and 2024: Enterprise Value tumbled 206.25% in 2022, then rose 29.04% in 2024.
- Amphastar Pharmaceuticals' Enterprise Value stood at -$156.3 million in 2022, then rose by 7.57% to -$144.5 million in 2023, then decreased by 6.45% to -$153.8 million in 2024, then decreased by 10.79% to -$170.4 million in 2025, then retreated by 0.43% to -$171.1 million in 2026.
- Business Quant data shows AMPH's Enterprise Value at -$171.1 million in Q1 2026, -$170.4 million in Q4 2025, and -$216.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | -882.82 Mn |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn | -3.65 Bn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | -1.68 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | -5.79 Bn |
| 5 | United Therapeutics | 22.19 Bn | 19.53 Bn | 683.80 Mn | -2.66 Bn |
| 6 | Viatris | 18.68 Bn | 17.79 Bn | 1.46 Bn | -886.50 Mn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | -389.80 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | -530.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | -164.00 Mn |
| 10 | Amphastar Pharmaceuticals | 933.76 Mn | 643.64 Mn | 93.47 Mn | -290.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -290.12 Mn |
| Mar 31, 2026 | -171.14 Mn |
| Dec 31, 2025 | -170.41 Mn |
| Sep 30, 2025 | -216.47 Mn |
| Jun 30, 2025 | -189.89 Mn |
| Mar 31, 2025 | -182.98 Mn |
| Dec 31, 2024 | -153.81 Mn |
| Sep 30, 2024 | -192.32 Mn |
| Jun 30, 2024 | -189.85 Mn |
| Mar 31, 2024 | -201.38 Mn |
| Dec 31, 2023 | -144.50 Mn |
| Sep 30, 2023 | -271.04 Mn |
| Jun 30, 2023 | -150.80 Mn |
| Mar 31, 2023 | -192.89 Mn |
| Dec 31, 2022 | -156.33 Mn |
| Sep 30, 2022 | -159.44 Mn |
| Jun 30, 2022 | -166.36 Mn |
| Mar 31, 2022 | -172.83 Mn |
| Dec 31, 2021 | -126.55 Mn |
| Sep 30, 2021 | -106.81 Mn |